title: [Improved immunosuppression leads to better kidney transplantations].
authors.affiliation: Transplantationskirurgi, transplantationscentrum, Skånes universitetssjukhus, Malmö. henrik.ekberg@med.lu.se
authors.forename: Henrik
authors.initials: H
authors.lastname: Ekberg
mesh_terms: D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D057915:Drug Substitution / Q000009:adverse effects / Q000592:standards; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000592:standards; D016568:Drugs, Generic / Q000009:adverse effects / Q000592:standards; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000592:standards*; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000592:standards / Q000627:therapeutic use; D010330:Patents as Topic; D055553:Prescription Drugs / Q000592:standards; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D016559:Tacrolimus / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D065095:Calcineurin Inhibitors; D016568:Drugs, Generic; D007166:Immunosuppressive Agents; D055553:Prescription Drugs; D016572:Cyclosporine; D058570:TOR Serine-Threonine Kinases; D009173:Mycophenolic Acid; D016559:Tacrolimus